At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 49 enrolled
Drug / intervention
Dexmedetomidine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effect of Topical Dexmedetomidine (0.0055%) on Intraocular Pressure in Healthy Eyes: a Randomized Controlled Trial
In Brief
A Phase 4 clinical trial evaluating Dexmedetomidine and Balanced salt solution for Glaucoma and Intraocular Pressure. Completed, enrolled 49 participants across 1 site.
Detailed Summary
Evaluate the short-term safety and efficacy of dexmedetomidine (0.0055%) drops on intraocular pressure (IOP) in healthy eyes.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGlaucoma, Intraocular Pressure
CountriesLebanon
Collaborators--
Timeline
Phase 4CompletedFinished
201820192020202120222023202420252026
Enrollment StartDec 2017
Primary CompletionJan 2018
Study CompletionApr 2018
First PostedOct 2018
TodayJul 2026
First PostedOct 1, 2018
Enrollment StartDec 1, 2017
Primary CompletionJan 1, 2018
Study CompletionApr 3, 2018
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 7.8 years ago
Interventions
Dexmedetomidinedrug
Instillation of eyedrops
Balanced salt solutiondrug
instillation of eyedrop